Pathologic Myopia clinical trials

Explore recruiting pathologic myopia clinical trials.

Recruiting pathologic myopia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pathologic Myopia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia

Poland, France, Germany, Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pathologic Myopia trials by city

Pathologic Myopia in Toronto Pathologic Myopia in Vancouver Pathologic Myopia in Montreal Pathologic Myopia in Calgary Pathologic Myopia in Edmonton Pathologic Myopia in Ottawa Pathologic Myopia in Winnipeg Pathologic Myopia in Quebec City Pathologic Myopia in Hamilton Pathologic Myopia in Kitchener Pathologic Myopia in London Pathologic Myopia in Halifax Pathologic Myopia in New York Pathologic Myopia in Los Angeles Pathologic Myopia in Chicago Pathologic Myopia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease